These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35771390)

  • 1. Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease.
    Ghoshal UC; Blaachandran A; Rai S; Misra A
    Indian J Gastroenterol; 2022 Aug; 41(4):405-414. PubMed ID: 35771390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.
    Ours TM; Fackler WK; Richter JE; Vaezi MF
    Am J Gastroenterol; 2003 Mar; 98(3):545-50. PubMed ID: 12650785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease.
    Karyampudi A; Ghoshal UC; Singh R; Verma A; Misra A; Saraswat VA
    J Neurogastroenterol Motil; 2017 Apr; 23(2):208-217. PubMed ID: 27585842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and gastroesophageal reflux disease: lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings.
    Gisbert JP; de Pedro A; Losa C; Barreiro A; Pajares JM
    J Clin Gastroenterol; 2001 Mar; 32(3):210-4. PubMed ID: 11246345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
    Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal acid breakthrough: pH, drugs and bugs.
    Tutuian R; Katz PO; Castell DO
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):441-3. PubMed ID: 15097034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
    Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.
    Peters FT; Kuipers EJ; Ganesh S; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
    Aliment Pharmacol Ther; 1999 Jul; 13(7):921-6. PubMed ID: 10383527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of CYP2C19 polymorphism and Helicobacter pylori status on the antisecretory effect of omeprazole in gastroesophageal reflux disease].
    Sohn YH; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Kim SJ
    Korean J Gastroenterol; 2006 Sep; 48(3):162-71. PubMed ID: 17047431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection.
    Sarnelli G; Ierardi E; Grasso R; Verde C; Bottiglieri ME; Nardone G; Budillon G; Cuomo R
    Dig Liver Dis; 2003 Mar; 35(3):151-6. PubMed ID: 12779068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
    Moayyedi P; Wason C; Peacock R; Walan A; Bardhan K; Axon AT; Dixon MF
    Helicobacter; 2000 Dec; 5(4):206-14. PubMed ID: 11179985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry.
    Chourasia D; Misra A; Tripathi S; Krishnani N; Ghoshal UC
    Indian J Gastroenterol; 2011 Feb; 30(1):12-21. PubMed ID: 21267690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection.
    Kawami N; Takenouchi N; Umezawa M; Hoshino S; Hanada Y; Hoshikawa Y; Sano H; Hoshihara Y; Nomura T; Uchida E; Iwakiri K
    Digestion; 2017; 95(2):140-145. PubMed ID: 28161707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.
    Güliter S; Kandilci U
    J Clin Gastroenterol; 2004 Oct; 38(9):750-5. PubMed ID: 15365399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
    Castro Fernández M; García Díaz E; Larraona JL; Rodríguez Hornillo MC; Lamas Rojas E; Núñez Hospital D; Pallarés Querol M
    Rev Esp Enferm Dig; 2006 Mar; 98(3):170-9. PubMed ID: 16737416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
    Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.